Potent Synergistic Effect of IL-3 and TNF on Matrix Metalloproteinase 9 Generation by Human Eosinophils
Overview
Biology
Authors
Affiliations
TNF (designated as TNF-α under previous nomenclature) is the preeminent activator of MMP-9 generation from a variety of cells including eosinophils. We have previously established that TNF strongly synergizes with IFN-γ and IL-4 for eosinophil synthesis of Th1- and Th2-type chemokines respectively. Thus, we sought to determine if TNF-induced synthesis of MMP-9 would be enhanced by the presence of Th1, Th2, or the eosinophil-associated common beta chain (βc) cytokines. Human blood eosinophils were cultured with TNF alone or in combination with either IFN-γ, IL-4, IL-3, IL-5, or GM-CSF. Concentrations and activities of MMP-9 in eosinophil culture supernates were measured by ELISA and gelatin zymography, mRNA transcription and stabilization by quantitative real-time PCR, and signaling events by immunoblotting and intracellular flow cytometric analysis. Individually, TNF, GM-CSF, or IL-3, but not IL-4 or IFN-γ, induced relatively small (<0.2 ng/ml) but statistically significant quantities of MMP-9. Remarkable synergistic synthesis of MMP-9 (ng/ml levels) occurred in response to TNF plus IL-3, GM-CSF or IL-5, in the order of IL-3>GM-CSF>IL-5. Zymography revealed that eosinophils release MMP-9 in its pro-form. Eosinophil stimulation with the combination of IL-3 plus TNF led to increased steady-state levels of MMP-9 mRNA, prolonged mRNA stabilization, and enhanced activation of ERK1/2 phosphorylation. Inhibition of NF-κB, MEK kinase, or p38 MAP kinase, but not JNK signaling pathways, diminished IL-3/TNF-induced MMP-9 mRNA and protein production. Thus, the synergistic regulation of eosinophil MMP-9 by IL-3 plus TNF likely involves cooperative interaction of multiple transcription factors downstream from ERK, p38, and NF-κB activation as well as post-transcriptional regulation of MMP-9 mRNA stabilization. Our data indicate that within microenvironments rich in βc-family cytokines and TNF, eosinophils are an important source of proMMP-9 and highlight a previously unrecognized role for synergistic interaction between TNF and βc-family cytokines, particularly IL-3, for proMMP-9 synthesis.
Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update.
Karakioulaki M, Eyerich K, Patsatsi A Am J Clin Dermatol. 2023; 25(2):195-212.
PMID: 38157140 PMC: 10866767. DOI: 10.1007/s40257-023-00832-1.
Bullous pemphigoid-What do we know about the most recent therapies?.
Zeng F, Murrell D Front Med (Lausanne). 2022; 9:1057096.
PMID: 36405625 PMC: 9669062. DOI: 10.3389/fmed.2022.1057096.
Mizuno Y, Shibata S, Ito Y, Taira H, Sugimoto E, Awaji K Front Immunol. 2022; 13:1013382.
PMID: 36311716 PMC: 9599390. DOI: 10.3389/fimmu.2022.1013382.
Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms.
Cole C, Vinay K, Borradori L, Amber K Front Immunol. 2022; 13:912876.
PMID: 35874745 PMC: 9300999. DOI: 10.3389/fimmu.2022.912876.
Eosinophils and melanoma: Implications for immunotherapy.
Robinson I, Santa Lucia G, Li A, Oberholtzer N, Plante J, Quinn K Pigment Cell Melanoma Res. 2021; 35(2):192-202.
PMID: 34927354 PMC: 9012984. DOI: 10.1111/pcmr.13025.